Search

Your search keyword '"Siva, Aksel"' showing total 36 results

Search Constraints

Start Over You searched for: Author "Siva, Aksel" Remove constraint Author: "Siva, Aksel" Publisher elsevier bv Remove constraint Publisher: elsevier bv
36 results on '"Siva, Aksel"'

Search Results

1. Elsevier - Best clinical paper: Underemployment, work hour reduction, and income loss: A global, multi-centered, cohort study of neuromyelitis optica

3. Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatment

4. Radiologically isolated syndrome

5. Infliximab for vascular involvement in Behçet's syndrome

6. Application of diagnostic criteria for optic neuritis – Authors' reply

8. mRNA versus inactivated virus COVID-19 vaccines in multiple sclerosis: humoral responses and protectivity–Does it matter?

9. Ocrelizumab in pediatric multiple sclerosis

11. Diagnosis and classification of optic neuritis

12. A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis

13. The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?

14. Myelin-oligodendrocyte glycoprotein antibody-associated disease

15. A comprehensive assessment of patient experience and disease-related awareness in multiple sclerosis: A questionnaire-based nation-wide survey in Turkey

17. Post Vaccination Optic Neuritis: Observations From the SARS-CoV-2 Pandemic

18. Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial

20. ‘Is RLS a harbinger and consequence of MS?: Striking results of the ‘RELOMS-T’ study’

22. Efficacy and Safety of Ocrelizumab in Patients with Relapsing-Remitting Multiple Sclerosis with a Suboptimal Response to Previous Disease-Modifying Therapies (1-Year Interim Results)

23. Management of skin, mucosa and joint involvement of Behçet’s syndrome: A systematic review for update of the EULAR recommendations for the management of Behçet’s syndrome

25. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

30. Assessment of aquaporin-4 (AQP4) antibody assays in European diagnostic centres

32. Neurofilament ELISA validation.

33. Neurofilament ELISA validation

36. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Catalog

Books, media, physical & digital resources